TCL Archive John Niederhuber named NCI chief operating officer; the surgeon was asked to leave two previous positions. October 7, 2005
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013